Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis

Telepharmacy-supported monitoring using validated ePROMs effectively captures longitudinal changes in HRQoL and symptom burden in patients with moderate-to-severe psoriasis. The achievement of predefined HRQoL targets supports their clinical relevance in real-world settings. These findings highlight the value of PROM-based, patient-centered digital follow-up and suggest that biologic-experienced patients and women may benefit from more tailored monitoring strategies.